These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde. Bondesson G; Hedbom C; Magnusson O; Stjernström NE Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658 [No Abstract] [Full Text] [Related]
10. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid. Högberg T; Bondesson G; Misiorny A; Stjernström NE Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658 [No Abstract] [Full Text] [Related]
11. Potential hypolipidemic agents. XX. Synthesis and lipid-lowering properties of annelated thiophenecarboxylic acids. Gronowitz S; Herslöf M; Svenson R; Bondesson G; Magnusson O; Stjernström NE Acta Pharm Suec; 1978; 15(5):368-81. PubMed ID: 747095 [No Abstract] [Full Text] [Related]
12. The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins. Gustafsson K; Kiessling H Z Versuchstierkd; 1982; 24(5-6):262-70. PubMed ID: 7170838 [No Abstract] [Full Text] [Related]
13. [Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids]. Kwapiszewski W; Borkowski L Acta Pol Pharm; 1987; 44(2):121-31. PubMed ID: 3434313 [No Abstract] [Full Text] [Related]
14. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives. Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)]. Sterner W; Chibanguza G; Metz G Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056 [TBL] [Abstract][Full Text] [Related]
16. [Fenofibrate: chemical development and differences with clofibrate (author's transl)]. Boucherle A Nouv Presse Med; 1980 Dec; 9(49):3721-3. PubMed ID: 7208336 [TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran. Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922 [TBL] [Abstract][Full Text] [Related]
18. Hypolipidemic activity of Indan--1--acetic acids. Adak M; Gupta JK Nepal Med Coll J; 2006 Mar; 8(1):22-6. PubMed ID: 16827085 [TBL] [Abstract][Full Text] [Related]
19. The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins. Gustafsson K; Kiessling H Z Versuchstierkd; 1982; 24(5-6):271-7. PubMed ID: 7170839 [No Abstract] [Full Text] [Related]
20. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents. Davies JE; Kellett DN Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]